
Management Change3 Aug 2026, 04:15 pm
GlaxoSmithKline Pharmaceuticals Ltd: Bhushan Akshikar Re-appointed MD
AI Summary
GlaxoSmithKline Pharmaceuticals Limited announced the re-appointment of Mr. Bhushan Akshikar as Managing Director for a term of two years, effective December 1, 2026. The Board of Directors also approved the un-audited standalone and consolidated financial results for the first quarter ended June 30, 2026. Additionally, Mr. Subesh Williams stepped down as Non-Executive Director, and Ms. Karine J F Natland will be appointed as a Non-Executive Director. The company reported revenue from operations of ₹92442 Lakhs for the quarter ended June 30, 2026.
Key Highlights
- Bhushan Akshikar re-appointed as MD for two years from Dec 1, 2026.
- Board approved Q1 FY27 un-audited financial results.
- Revenue from operations stood at ₹92442 Lakhs for Q1 FY27.
- Karine J F Natland appointed as Non-Executive Director.
- Subesh Williams stepped down as Non-Executive Director.
Price Impact
More from GLAXO
More in Management Change